ASTELLAS PHARMA UNSP.ADR Cash Flow Reinvestment Rate
ASTELLAS PHARMA UNSP.ADR cash flow reinvestment rate. ASTELLAS PHARMA UNSP.ADR (YPHA) has a Cash Flow Reinvestment Rate of 0.36x as of March 2025, reinvesting €70.25 Billion (capex €57.33 Billion plus investments €12.92 Billion) from operating cash flow of €194.51 Billion. Explore how well can ASTELLAS PHARMA UNSP.ADR service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ASTELLAS PHARMA UNSP.ADR (2022–2025)
Cash flow reinvestment rate of ASTELLAS PHARMA UNSP.ADR from 2022 to 2025. Historical reinvestment intensity for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Explore ASTELLAS PHARMA UNSP.ADR capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
ASTELLAS PHARMA UNSP.ADR Cash Flow Reinvestment Rate by Year (2022–2025)
ASTELLAS PHARMA UNSP.ADR cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for ASTELLAS PHARMA UNSP.ADR. For the full cash flow conversion analysis, see cash flow conversion of ASTELLAS PHARMA UNSP.ADR.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | €70.25 Billion | €194.51 Billion | €57.33 Billion | ▼ -24.5% |
| 2024 | 0.48x | €82.50 Billion | €172.47 Billion | €82.50 Billion | ▲ +55.0% |
| 2023 | 0.31x | €101.17 Billion | €327.77 Billion | €88.54 Billion | ▼ -3.1% |
| 2022 | 0.32x | €82.02 Billion | €257.44 Billion | €76.45 Billion | — |